Medical Education grants pharmaceutical companies
IMPORTANT NEW INFORMATION FOR APPLICANTS REGARDING “PHYSICIAN PAYMENTS SUNSHINE ACT”
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) has implemented new business practices to satisfy the government reporting requirements under the Physician Payments Sunshine Act, which was part of the 2010 Patient Protection and Affordable Care Act.
The Final Rule regarding transparency reporting was released by CMS on February 1, 2013 and requires applicable manufacturers (e.g., BIPI) to collect and annually report payments and other transfers of value provided to U.S.-licensed practitioners (i.e., MDs/DOs, chiropractors, dentists, podiatrists and chiropractors) and certain Teaching Hospitals (“Covered Recipients”). BIPI provides both direct and indirect transfers of value to Covered Recipients through medical education grants.
Boehringer Ingelheim Pharmaceuticals, Inc. will begin to report data on transfers of value collected between August 1, 2013 and the end of 2013 to CMS by March 31, 2014 and annually for each calendar year. As a result, these reporting requirements are effective immediately. To provide greater clarity surrounding BIPI’s reporting requirements as it pertains to the” Physician Payments Sunshine Act” under medical education grants, please refer to the document “Medical Education Grants Sunshine Reporting Requirements”.
This document will describe the grant recipient’s (educational provider’s) responsibilities to report to BIPI certain indirect payments to Covered Recipients. The document addresses those scenarios considered relevant by BIPI for reporting which are inclusive of speaker and attendee payment reporting for: (1) accredited HCP education, (2) non-accredited HCP education, and (3) non-accredited patient and community medical education.
You might also like
Guide to Effective Grant Writing: How to Write a Successful NIH Grant Application
GMC taps director for new residency program — Gwinnettdailypost.com
“We will provide students with a solid medical education foundation to practice internal medicine in a hospital or outpatient setting.” Prior to getting tapped for GMC position, Bates also served as director of FACES HIV Program at Nationwide Children ..
What pharmaceutical company manufactures the medication buprenorphine
Reckktt benckiser is the make of the brand name Suboxone and Subutex.
I know of 2 other companies that make buprenorphine and buprenorphine with naloxone...those companies are Teva and Roxanne pharmaceuticals. I do not know if there are other generic makers.